COVID-19 and Pregnancy
(UPDATE 09/16/2024)
Covid disease has become endemic with seasonal flares. Pregnant women do not appear to be at higher likelihood to acquire the coronavirus than non-pregnant women, but the disease course of COVID-19 may be more severe. For this reason, take extra care in preventing virus exposure. More than 50% of women who get ill from the coronavirus got it from someone who did not have symptoms at the time. You have to do more than just “avoid sick people”! Vaccination is your best defense against severe disease, hospitalization, prenatal complications, and death.
If you have COVID-19 symptoms or you are concerned that you may have been exposed to COVID-19, please get tested. We cannot see patients with symptoms of Covid, or test patients for Covid. Your primary care provider may do testing in their office. Home tests are adequate as well, and consider swabbing both your throat and nose. In general, if you are experiencing fever, cough or shortness of breath, we request you call the office to postpone your appointment.
If you do acquire the newest strains of COVID-19, it is likely that you will only have mild disease (no shortness of breath) and can remain at home. Notify our office if you have COVID-19. We will have regular telephone contact with you if needed, assessing for worsening of your illness and the need for hospital care. We will also reschedule your prenatal appointments to accommodate your isolation.
IF YOU GET COVID DISEASE WHILE PREGNANT…
Notify
Isolate
Home Care
Therapy
- Paxlovid (nirmatrelvir/ritonavir) is an oral antiviral pill combination. The medication has received an Emergency Use Authorization in the United States, including for pregnant patients. In a trial in adult outpatients with at least one risk factor for severe disease, nirmatrelvir-ritonavir, administered within three days of symptom onset, reduced the risk of hospitalization or death. The Society for Maternal Fetal Medicine issued a statement supporting the use of Paxlovid in pregnancy. Although only minimal reproductive safety data from animal studies are available for nirmatrelvir (e.g., reduced fetal body weights in rabbits when exposed to doses 10-fold higher than authorized human maternal doses), extensive data are available for ritonavir in patients with HIV and no increased risk of overall teratogenic effects has been observed following first-trimester exposure. There are no data on the presence of nirmatrelvir in breast milk, the effects on the breastfed infant, or the effects on milk production. Limited data suggest that ritonavir is present in breast milk, but no information is available on the effects on the breastfed infant or the effects on milk production. Lactation is not a contraindication to use, but interruption of breast feeding during maternal treatment may be prudent.
- Paxlovid is now our preferred therapeutic for pregnant women. It has the equivalent effect as monoclonal antibody treatment, but is more available and requires fewer resources. Side-effects are very rare (<1%) and include diarrhea, altered taste, metallic taste, hypertension, and muscle aches.
> The typical dose is 300 mg nirmatrelvir (two 150 mg tablets) with 100 mg ritonavir (one 100 mg tablet) — with all three tablets taken together, twice daily for 5 days (30 pills in total). - Paxlovid is now available at most major community pharmacies.
- If you would like Arbor ObGyn to prescribe the antiviral pill treatment, call us or send a portal message indicating your desire to take Paxlovid, AND you pharmacy location.
- Please review the UNC Health Paxlovid Infosheet, and emergency use Patient Fact Sheet. Also, view a useful video from UNC Health on Paxlovid therapeutic pills.
- Paxlovid is now our preferred therapeutic for pregnant women. It has the equivalent effect as monoclonal antibody treatment, but is more available and requires fewer resources. Side-effects are very rare (<1%) and include diarrhea, altered taste, metallic taste, hypertension, and muscle aches.
Prenatal Care
In general, your care after recovering from COVID-19 will not differ from your original prenatal care plan. No additional fetal testing such as growth ultrasounds, non-stress tests or biophysical profiles are recommended.
Delivery
Ideally, birth will occur sometime after recovery. Induction of labor and cesarean birth are not recommended as a treatment plan for a history of asymptomatic or non-severe prenatal Covid infection.
